Oxygen-limiting conditions enrich for fimbriate cells of uropathogenic Proteus mirabilis and Escherichia coli.

PubWeight™: 0.90‹?›

🔗 View Article (PMC 2648204)

Published in J Bacteriol on December 29, 2008

Authors

M Chelsea Lane1, Xin Li, Melanie M Pearson, Amy N Simms, Harry L T Mobley

Author Affiliations

1: Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, 48109-0620, USA.

Articles citing this

Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol (2015) 2.06

Host-pathogen interactions in urinary tract infection. Nat Rev Urol (2010) 1.94

Escherichia coli global gene expression in urine from women with urinary tract infection. PLoS Pathog (2010) 1.65

Merging mythology and morphology: the multifaceted lifestyle of Proteus mirabilis. Nat Rev Microbiol (2012) 1.48

Bacterial genome instability. Microbiol Mol Biol Rev (2014) 1.31

Transcriptome of Proteus mirabilis in the murine urinary tract: virulence and nitrogen assimilation gene expression. Infect Immun (2011) 0.90

Characterization of 17 chaperone-usher fimbriae encoded by Proteus mirabilis reveals strong conservation. J Med Microbiol (2014) 0.90

Proteus mirabilis and Urinary Tract Infections. Microbiol Spectr (2015) 0.90

More than one way to control hair growth: regulatory mechanisms in enterobacteria that affect fimbriae assembled by the chaperone/usher pathway. J Bacteriol (2011) 0.88

Type 1 fimbriae contribute to catheter-associated urinary tract infections caused by Escherichia coli. J Bacteriol (2013) 0.81

Transcriptional analysis of the MrpJ network: modulation of diverse virulence-associated genes and direct regulation of mrp fimbrial and flhDC flagellar operons in Proteus mirabilis. Infect Immun (2015) 0.78

ArcA Controls Metabolism, Chemotaxis, and Motility Contributing to the Pathogenicity of Avian Pathogenic Escherichia coli. Infect Immun (2015) 0.77

Distinct Residues Contribute to Motility Repression and Autoregulation in the Proteus mirabilis Fimbria-Associated Transcriptional Regulator AtfJ. J Bacteriol (2016) 0.76

From Catheter to Kidney Stone: The Uropathogenic Lifestyle of Proteus mirabilis. Trends Microbiol (2016) 0.75

New aspects of RpoE in uropathogenic Proteus mirabilis. Infect Immun (2014) 0.75

The plasmid-encoded Ipf and Klf fimbriae display different expression and varying roles in the virulence of Salmonella enterica serovar Infantis in mouse vs. avian hosts. PLoS Pathog (2017) 0.75

Articles cited by this

Cholera toxin transcriptional activator toxR is a transmembrane DNA binding protein. Cell (1987) 11.04

Common themes in microbial pathogenicity revisited. Microbiol Mol Biol Rev (1997) 10.52

A physiological role for DNA supercoiling in the osmotic regulation of gene expression in S. typhimurium and E. coli. Cell (1988) 6.80

The ability of Salmonella to enter mammalian cells is affected by bacterial growth state. Proc Natl Acad Sci U S A (1990) 6.57

An invertible element of DNA controls phase variation of type 1 fimbriae of Escherichia coli. Proc Natl Acad Sci U S A (1985) 6.00

Ascending, unobstructed urinary tract infection in mice caused by pyelonephritogenic Escherichia coli of human origin. Infect Immun (1983) 5.10

Type 1 pilus-mediated bacterial invasion of bladder epithelial cells. EMBO J (2000) 5.03

Pyelonephritogenic Escherichia coli and killing of cultured human renal proximal tubular epithelial cells: role of hemolysin in some strains. Infect Immun (1990) 4.94

Two regulatory fim genes, fimB and fimE, control the phase variation of type 1 fimbriae in Escherichia coli. EMBO J (1986) 4.58

Selective outgrowth of fimbriate bacteria in static liquid medium. J Bacteriol (1970) 3.69

Transcriptome of uropathogenic Escherichia coli during urinary tract infection. Infect Immun (2004) 3.28

Periplasmic stress and ECF sigma factors. Annu Rev Microbiol (2001) 3.21

Urease-positive bacteriuria and obstruction of long-term urinary catheters. J Clin Microbiol (1987) 3.08

Bacterial adhesins: common themes and variations in architecture and assembly. J Bacteriol (1999) 3.01

Gene conversion involving the pilin structural gene correlates with pilus+ in equilibrium with pilus- changes in Neisseria gonorrhoeae. Cell (1986) 2.98

Direct evidence that the FimH protein is the mannose-specific adhesin of Escherichia coli type 1 fimbriae. Infect Immun (1990) 2.94

Fimbrial phase variation in Bordetella pertussis: a novel mechanism for transcriptional regulation. EMBO J (1990) 2.53

Complete genome sequence of uropathogenic Proteus mirabilis, a master of both adherence and motility. J Bacteriol (2008) 2.47

Fimbrial phase variation in Escherichia coli: dependence on integration host factor and homologies with other site-specific recombinases. J Bacteriol (1987) 2.36

Metastable regulation of type 1 piliation in Escherichia coli and isolation and characterization of a phenotypically stable mutant. J Bacteriol (1986) 2.24

Integration host factor is required for the DNA inversion that controls phase variation in Escherichia coli. Proc Natl Acad Sci U S A (1987) 2.20

Roles of fimB and fimE in site-specific DNA inversion associated with phase variation of type 1 fimbriae in Escherichia coli. J Bacteriol (1991) 2.17

Transposon mutagenesis in Proteus mirabilis. J Bacteriol (1991) 2.14

Cpx signaling pathway monitors biogenesis and affects assembly and expression of P pili. EMBO J (2001) 2.08

Rapid site-specific DNA inversion in Escherichia coli mutants lacking the histonelike protein H-NS. J Bacteriol (1991) 2.01

Succinate dehydrogenase and fumarate reductase from Escherichia coli. Biochim Biophys Acta (2002) 1.91

Oxidative protein folding in bacteria. Mol Microbiol (2002) 1.87

Role of motility in the colonization of uropathogenic Escherichia coli in the urinary tract. Infect Immun (2005) 1.80

DsbA is required for stability of the type IV pilin of enteropathogenic escherichia coli. Mol Microbiol (1996) 1.80

Lrp stimulates phase variation of type 1 fimbriation in Escherichia coli K-12. J Bacteriol (1993) 1.78

Proteus mirabilis genes that contribute to pathogenesis of urinary tract infection: identification of 25 signature-tagged mutants attenuated at least 100-fold. Infect Immun (2004) 1.76

Interaction of FimB and FimE with the fim switch that controls the phase variation of type 1 fimbriae in Escherichia coli K-12. Mol Microbiol (1996) 1.73

Proteus mirabilis flagella and MR/P fimbriae: isolation, purification, N-terminal analysis, and serum antibody response following experimental urinary tract infection. Infect Immun (1991) 1.72

The CpxRA signal transduction system of Escherichia coli: growth-related autoactivation and control of unanticipated target operons. J Bacteriol (1999) 1.71

The use of flow cytometry to detect expression of subunits encoded by 11 Salmonella enterica serotype Typhimurium fimbrial operons. Mol Microbiol (2003) 1.71

Haemagglutinins and fimbriae of Morganella, Proteus and Providencia. J Med Microbiol (1982) 1.69

Uropathogenicity in rats and mice of Providencia stuartii from long-term catheterized patients. J Urol (1987) 1.66

The tcp gene cluster of Vibrio cholerae. Gene (1997) 1.65

Epigenetic phase variation of the pap operon in Escherichia coli. Trends Microbiol (1996) 1.63

Type 1 fimbriation and fimE mutants of Escherichia coli K-12. J Bacteriol (1991) 1.61

PapD chaperone function in pilus biogenesis depends on oxidant and chaperone-like activities of DsbA. Proc Natl Acad Sci U S A (1994) 1.58

Assessment of virulence of uropathogenic Escherichia coli type 1 fimbrial mutants in which the invertible element is phase-locked on or off. Infect Immun (2002) 1.56

In vivo phase variation of MR/P fimbrial gene expression in Proteus mirabilis infecting the urinary tract. Mol Microbiol (1997) 1.40

LeuX tRNA-dependent and -independent mechanisms of Escherichia coli pathogenesis in acute cystitis. Mol Microbiol (2007) 1.37

Regulation of type 1 fimbriae by unlinked FimB- and FimE-like recombinases in uropathogenic Escherichia coli strain CFT073. Infect Immun (2006) 1.35

In vivo dynamics of type 1 fimbria regulation in uropathogenic Escherichia coli during experimental urinary tract infection. Infect Immun (2001) 1.31

Repression of bacterial motility by a novel fimbrial gene product. EMBO J (2001) 1.30

The Pai-associated leuX specific tRNA5(Leu) affects type 1 fimbriation in pathogenic Escherichia coli by control of FimB recombinase expression. Mol Microbiol (1997) 1.23

Requirement of MrpH for mannose-resistant Proteus-like fimbria-mediated hemagglutination by Proteus mirabilis. Infect Immun (1999) 1.20

Identification of MrpI as the sole recombinase that regulates the phase variation of MR/P fimbria, a bladder colonization factor of uropathogenic Proteus mirabilis. Mol Microbiol (2002) 1.14

Coordinate gene regulation by fimbriae-induced signal transduction. EMBO J (2001) 1.14

HbiF regulates type 1 fimbriation independently of FimB and FimE. Infect Immun (2006) 1.11

Identification of virulence determinants in uropathogenic Proteus mirabilis using signature-tagged mutagenesis. J Med Microbiol (2008) 1.08

The type III secretion system of Proteus mirabilis HI4320 does not contribute to virulence in the mouse model of ascending urinary tract infection. J Med Microbiol (2007) 1.04

Mannose-resistant Proteus-like fimbriae are produced by most Proteus mirabilis strains infecting the urinary tract, dictate the in vivo localization of bacteria, and contribute to biofilm formation. Infect Immun (2004) 1.03

Fimbrial haemagglutinins in Enterobacter species. J Gen Microbiol (1983) 1.02

Multiple fimbrial haemagglutinins in Serratia species. Med Microbiol Immunol (1983) 1.00

Control of Escherichia coli type 1 fimbrial gene expression in stationary phase: a negative role for RpoS. Mol Gen Genet (1997) 0.98

Repression of motility during fimbrial expression: identification of 14 mrpJ gene paralogues in Proteus mirabilis. Mol Microbiol (2008) 0.96

The bacterial flagellar switch complex is getting more complex. EMBO J (2008) 0.96

The high-affinity phosphate transporter Pst is a virulence factor for Proteus mirabilis during complicated urinary tract infection. FEMS Immunol Med Microbiol (2008) 0.91

Stimulation of Escherichia coli F-18Col- type-1 fimbriae synthesis by leuX. FEMS Microbiol Lett (1994) 0.78

Articles by these authors

TRIBUTE: a phase III trial of erlotinib hydrochloride (OSI-774) combined with carboplatin and paclitaxel chemotherapy in advanced non-small-cell lung cancer. J Clin Oncol (2005) 7.55

Stereotaxic white matter atlas based on diffusion tensor imaging in an ICBM template. Neuroimage (2008) 6.58

Tract probability maps in stereotaxic spaces: analyses of white matter anatomy and tract-specific quantification. Neuroimage (2007) 5.23

Resequencing 50 accessions of cultivated and wild rice yields markers for identifying agronomically important genes. Nat Biotechnol (2011) 4.84

The DNA methylome of human peripheral blood mononuclear cells. PLoS Biol (2010) 4.25

The pulvinar regulates information transmission between cortical areas based on attention demands. Science (2012) 4.14

Atlas-based whole brain white matter analysis using large deformation diffeomorphic metric mapping: application to normal elderly and Alzheimer's disease participants. Neuroimage (2009) 3.74

Gradient-index meta-surfaces as a bridge linking propagating waves and surface waves. Nat Mater (2012) 3.42

Transcriptome of uropathogenic Escherichia coli during urinary tract infection. Infect Immun (2004) 3.28

Silencing by small RNAs is linked to endosomal trafficking. Nat Cell Biol (2009) 3.25

Magnetic field and tissue dependencies of human brain longitudinal 1H2O relaxation in vivo. Magn Reson Med (2007) 3.23

A gain-of-function mutation in a plant disease resistance gene leads to constitutive activation of downstream signal transduction pathways in suppressor of npr1-1, constitutive 1. Plant Cell (2003) 3.00

Human brain white matter atlas: identification and assignment of common anatomical structures in superficial white matter. Neuroimage (2008) 2.86

The macrophage-inducible C-type lectin, mincle, is an essential component of the innate immune response to Candida albicans. J Immunol (2008) 2.71

The phytochrome-interacting transcription factor, PIF3, acts early, selectively, and positively in light-induced chloroplast development. Proc Natl Acad Sci U S A (2004) 2.71

On the origin of new genes in Drosophila. Genome Res (2008) 2.69

Mutations in Aspergillus fumigatus resulting in reduced susceptibility to posaconazole appear to be restricted to a single amino acid in the cytochrome P450 14alpha-demethylase. Antimicrob Agents Chemother (2003) 2.66

TROSPA, an Ixodes scapularis receptor for Borrelia burgdorferi. Cell (2004) 2.62

Expression of flagella is coincident with uropathogenic Escherichia coli ascension to the upper urinary tract. Proc Natl Acad Sci U S A (2007) 2.56

Outsourcing CO2 within China. Proc Natl Acad Sci U S A (2013) 2.51

Three-dimensional analysis of post-Golgi carrier exocytosis in epithelial cells. Nat Cell Biol (2003) 2.50

Defining genomic islands and uropathogen-specific genes in uropathogenic Escherichia coli. J Bacteriol (2007) 2.50

C. elegans screen identifies autophagy genes specific to multicellular organisms. Cell (2010) 2.50

MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by targeting prohibitin. Cancer Lett (2008) 2.48

Complete genome sequence of uropathogenic Proteus mirabilis, a master of both adherence and motility. J Bacteriol (2008) 2.47

Multi-contrast human neonatal brain atlas: application to normal neonate development analysis. Neuroimage (2011) 2.41

Knockout analysis of Arabidopsis transcription factors TGA2, TGA5, and TGA6 reveals their redundant and essential roles in systemic acquired resistance. Plant Cell (2003) 2.35

Variation of the relaxographic "shutter-speed" for transcytolemmal water exchange affects the CR bolus-tracking curve shape. Magn Reson Med (2003) 2.23

Contour-based object tracking with occlusion handling in video acquired using mobile cameras. IEEE Trans Pattern Anal Mach Intell (2004) 2.22

Atlas-guided tract reconstruction for automated and comprehensive examination of the white matter anatomy. Neuroimage (2010) 2.21

Mucosal immunization with iron receptor antigens protects against urinary tract infection. PLoS Pathog (2009) 2.14

The proteasome inhibitor, bortezomib suppresses primary myeloma and stimulates bone formation in myelomatous and nonmyelomatous bones in vivo. Am J Hematol (2009) 2.12

Comparison of intravitreal triamcinolone acetonide versus intravitreal bevacizumab as the primary treatment of clinically significant macular edema. Retina (2015) 2.08

A putative nucleoporin 96 Is required for both basal defense and constitutive resistance responses mediated by suppressor of npr1-1,constitutive 1. Plant Cell (2005) 2.06

Single base-resolution methylome of the silkworm reveals a sparse epigenomic map. Nat Biotechnol (2010) 2.03

Multi-contrast large deformation diffeomorphic metric mapping for diffusion tensor imaging. Neuroimage (2009) 2.01

Laparoscopic versus conventional appendectomy--a meta-analysis of randomized controlled trials. BMC Gastroenterol (2010) 1.99

Syntaxin 2 and endobrevin are required for the terminal step of cytokinesis in mammalian cells. Dev Cell (2003) 1.99

Nuclear pore complex component MOS7/Nup88 is required for innate immunity and nuclear accumulation of defense regulators in Arabidopsis. Plant Cell (2009) 1.96

Host-pathogen interactions in urinary tract infection. Nat Rev Urol (2010) 1.94

Regulation of cell death and innate immunity by two receptor-like kinases in Arabidopsis. Cell Host Microbe (2009) 1.93

Isolation and characterization of phyC mutants in Arabidopsis reveals complex crosstalk between phytochrome signaling pathways. Plant Cell (2003) 1.90

Atlas-based analysis of neurodevelopment from infancy to adulthood using diffusion tensor imaging and applications for automated abnormality detection. Neuroimage (2010) 1.89

Meningiomas in children and adolescents: a meta-analysis of individual patient data. Lancet Oncol (2011) 1.88

The clinical pathology of severe acute respiratory syndrome (SARS): a report from China. J Pathol (2003) 1.83

Role of motility in the colonization of uropathogenic Escherichia coli in the urinary tract. Infect Immun (2005) 1.80

Loss of function of OsDCL1 affects microRNA accumulation and causes developmental defects in rice. Plant Physiol (2005) 1.77

A double-blind, randomized, controlled trial of amphotericin B colloidal dispersion versus amphotericin B for treatment of invasive aspergillosis in immunocompromised patients. Clin Infect Dis (2002) 1.77

Chemical-genomic dissection of the CTD code. Nat Struct Mol Biol (2010) 1.76

Proteus mirabilis genes that contribute to pathogenesis of urinary tract infection: identification of 25 signature-tagged mutants attenuated at least 100-fold. Infect Immun (2004) 1.76

MicroRNA-9 inhibits ovarian cancer cell growth through regulation of NF-kappaB1. FEBS J (2009) 1.74

Neonatal DNA methylation profile in human twins is specified by a complex interplay between intrauterine environmental and genetic factors, subject to tissue-specific influence. Genome Res (2012) 1.73

BLADE-ON-PETIOLE-dependent signaling controls leaf and floral patterning in Arabidopsis. Plant Cell (2005) 1.73

Meta-analysis on the relationship between nonsteroidal anti-inflammatory drug use and gastric cancer. Eur J Cancer Prev (2010) 1.72

Clonal persistence and evolution during a decade of recurrent melanoma. J Invest Dermatol (2006) 1.69

Mouse pachytene checkpoint 2 (trip13) is required for completing meiotic recombination but not synapsis. PLoS Genet (2007) 1.68

Unlocking the potential of cation-disordered oxides for rechargeable lithium batteries. Science (2014) 1.67

Fitness of Escherichia coli during urinary tract infection requires gluconeogenesis and the TCA cycle. PLoS Pathog (2009) 1.67

ETHYLENE INSENSITIVE3 and ETHYLENE INSENSITIVE3-LIKE1 repress SALICYLIC ACID INDUCTION DEFICIENT2 expression to negatively regulate plant innate immunity in Arabidopsis. Plant Cell (2009) 1.67

A gonococcal efflux pump system enhances bacterial survival in a female mouse model of genital tract infection. Infect Immun (2003) 1.66

Evidence for shutter-speed variation in CR bolus-tracking studies of human pathology. NMR Biomed (2005) 1.65

Escherichia coli global gene expression in urine from women with urinary tract infection. PLoS Pathog (2010) 1.65

Seroadaptive practices: association with HIV acquisition among HIV-negative men who have sex with men. PLoS One (2012) 1.64

Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways. J Pathol (2004) 1.62

MicroRNA-224 is involved in transforming growth factor-beta-mediated mouse granulosa cell proliferation and granulosa cell function by targeting Smad4. Mol Endocrinol (2010) 1.61

Impaired M. tuberculosis-mediated apoptosis in alveolar macrophages from HIV+ persons: potential role of IL-10 and BCL-3. J Leukoc Biol (2009) 1.61

Uropathogenic Escherichia coli outer membrane antigens expressed during urinary tract infection. Infect Immun (2007) 1.60

Body iron stores and dietary iron intake in relation to diabetes in adults in North China. Diabetes Care (2007) 1.59

Cyclophosphamide creates a receptive microenvironment for prostate cancer skeletal metastasis. Cancer Res (2012) 1.58

Regulation of the cell cycle gene, BTG2, by miR-21 in human laryngeal carcinoma. Cell Res (2009) 1.58

Transcriptional patterns, biomarkers and pathways characterizing nasopharyngeal carcinoma of Southern China. J Transl Med (2008) 1.57

Assessment of virulence of uropathogenic Escherichia coli type 1 fimbrial mutants in which the invertible element is phase-locked on or off. Infect Immun (2002) 1.56

Sat, the secreted autotransporter toxin of uropathogenic Escherichia coli, is a vacuolating cytotoxin for bladder and kidney epithelial cells. Infect Immun (2002) 1.56

Vaxign: the first web-based vaccine design program for reverse vaccinology and applications for vaccine development. J Biomed Biotechnol (2010) 1.55

Gene expression profiles and transcription factors involved in parathyroid hormone signaling in osteoblasts revealed by microarray and bioinformatics. J Biol Chem (2003) 1.53

The magnetic resonance shutter speed discriminates vascular properties of malignant and benign breast tumors in vivo. Proc Natl Acad Sci U S A (2008) 1.53

The chondrocyte clock gene Bmal1 controls cartilage homeostasis and integrity. J Clin Invest (2015) 1.52

Altered microRNA expression in patients with non-obstructive azoospermia. Reprod Biol Endocrinol (2009) 1.51

Suppression of hepatitis B virus replication by microRNA-199a-3p and microRNA-210. Antiviral Res (2010) 1.51

Alteration of sensory neurons and spinal response to an experimental osteoarthritis pain model. Arthritis Rheum (2010) 1.51

Androgenetic haploid embryonic stem cells produce live transgenic mice. Nature (2012) 1.51

Regulation of the transcription factor NF-kappaB1 by microRNA-9 in human gastric adenocarcinoma. Mol Cancer (2010) 1.50

A folate- and methyl-deficient diet alters the expression of DNA methyltransferases and methyl CpG binding proteins involved in epigenetic gene silencing in livers of F344 rats. J Nutr (2006) 1.50

An importin alpha homolog, MOS6, plays an important role in plant innate immunity. Curr Biol (2005) 1.50

Quantitative profile of the uropathogenic Escherichia coli outer membrane proteome during growth in human urine. Infect Immun (2007) 1.50

Anti-apoptotic activity of gentiopicroside in D-galactosamine/lipopolysaccharide-induced murine fulminant hepatic failure. Chem Biol Interact (2010) 1.49

The IrgA homologue adhesin Iha is an Escherichia coli virulence factor in murine urinary tract infection. Infect Immun (2005) 1.49

Troglitazone inhibits cell proliferation by attenuation of epidermal growth factor receptor signaling independent of peroxisome proliferator-activated receptor gamma. Cell Res (2009) 1.48

Merging mythology and morphology: the multifaceted lifestyle of Proteus mirabilis. Nat Rev Microbiol (2012) 1.48

Correction of B0 susceptibility induced distortion in diffusion-weighted images using large-deformation diffeomorphic metric mapping. Magn Reson Imaging (2008) 1.48

Waging war against uropathogenic Escherichia coli: winning back the urinary tract. Infect Immun (2009) 1.46

MicroRNA-214 is aberrantly expressed in cervical cancers and inhibits the growth of HeLa cells. IUBMB Life (2009) 1.46

A report of 918 cases of circumcision with the Shang Ring: comparison between children and adults. Urology (2013) 1.46

Mediation of multiple pathways regulating cell proliferation, migration, and apoptosis in the human malignant glioma cell line U87MG via unphosphorylated STAT1: laboratory investigation. J Neurosurg (2013) 1.44

Fimbrial profiles predict virulence of uropathogenic Escherichia coli strains: contribution of ygi and yad fimbriae. Infect Immun (2011) 1.44

B cells "transduced" with TAT-fusion proteins can induce tolerance and protect mice from diabetes and EAE. Clin Immunol (2011) 1.44

Improved seedless hydrothermal synthesis of dense and ultralong ZnO nanowires. Nanotechnology (2011) 1.43

Galanin mediates the pathogenesis of cerulein-induced acute pancreatitis in the mouse. Pancreas (2010) 1.43

Recombinant tissue plasminogen activator (alteplase) for restoration of function to occluded central venous catheters in pediatric patients. J Pediatr Hematol Oncol (2003) 1.43